18F-florbetaben: Clinical Trials

7 trials of 18F-florbetaben, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 recruiting, 1 active not recruiting. 3 Phase 1, 3 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 13Recruiting 2, Completed 1
Phase 23Active not recruiting 1, Completed 1, Recruiting 1
Not applicable1Completed 1

Follow 18F-florbetaben: new trials by email Literature Review of 18F-florbetaben trials Research Report on 18F-florbetaben

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
18F-PF974, 18F-florbetaben - Alzheimer s Disease, Mild Cognitive Impairment
Phase 1RecruitingNational Institute of Mental Health (NIMH)902026-11-092026-11-04
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
11C-MC1, 11C-PS13, 18f-florbetaben - Parkinson's Disease, Dementia
Phase 1RecruitingNational Institute of Mental Health (NIMH)1842021-08-172026-11-02
Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease
11C-ER176, 18F-florbetaben - Alzheimer Disease
Phase 2Active not recruitingColumbia University1072021-05-112026-05-14
Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease
11C-ER176, 18F-MK6240, 18F-Florbetaben - Alzheimer Disease
Phase 2RecruitingColumbia University1002020-11-172026-07-06
Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults
18F-MK-6240, 18F-Florbetaben - Alzheimer Disease
Phase 1CompletedAdam Brickman1452019-03-222025-08-01
Neuraceq™ PET for Detection of Brain Changes in Young Athletes Post-concussion
NeuraCeq PET imaging with intravenous (IV) dose of 300MBq of Neuraceq™ ([F-18]Florbetaben) - Concussion, Brain
Not applicableCompletedDartmouth-Hitchcock Medical Center152017-07-132024-02-28
Imaging Inflammation in Alzheimer's Disease
11C-PBR28, 18F-Florbetaben, Lumbar puncture (optional) - Alzheimer's Disease
Phase 2CompletedPatrick Lao602016-06-012025-03-05

Conditions studied

Alzheimer Disease (5)  ·  Cognitive Dysfunction (5)  ·  Inflammation (4)  ·  Brain Concussion (1)  ·  Dementia (1)  ·  Parkinson Disease (1)  ·  Pick Disease of the Brain (1)

Sponsors

Columbia University (2)  ·  National Institute of Mental Health (NIMH) (2)  ·  Adam Brickman (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  Patrick Lao (1)

Countries

United States (7)

Top investigators

Adam M. Brickman, Ph.D. (1)  ·  Marc A Seltzer, MD (1)  ·  Patrick J Lao (1)  ·  Patrick J. Lao, PhD (1)  ·  Paul A Parcon, M.D. (1)  ·  Philip De Jager, MD (1)  ·  Robert B Innis, M.D. (1)

Results publications

PMID 33646153, PMID 39542698, PMID 42083927

NIH funding

1RF1AG058067-01A1 (1), K23AG052633 (1), R01AG063888 (1), RF1AG070438 (1)